GlassScriptPhysician profile
Jason D Kreiner
NPI 1851672208
$18,088.60
in general payments reported to CMS, 2019-2025
43 companies · $2,525 in 2025
The $2,525 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,200 · 2020: $2,050 · 2021: $1,669 · 2022: $1,981 · 2023: $4,509 · 2024: $2,154 · 2025: $2,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,081 · Travel and Lodging: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,081.49 |
| Travel and Lodging | $1,106.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $4,868.26 | 2019-2023 | Intracept |
| Nevro Corp. | $2,685.51 | 2019-2024 | Senza |
| Boston Scientific Corporation | $2,646.69 | 2021-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $2,392.76 | 2019 | |
| Vertos Medical, INC. | $1,109.36 | 2019-2023 | Mild Device Kit |
| Saluda Medical Americas, INC. | $647.73 | 2024-2025 | Evoke |
| Abbvie INC. | $441.31 | 2022-2025 | |
| Horizon Therapeutics Plc | $441.24 | 2019-2022 | |
| Abbott Laboratories | $303.67 | 2020-2025 | Proclaim |
| Globus Medical, INC. | $235.93 | 2025 | Senza |
| Nalu Medical, INC. | $179.30 | 2023-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $174.83 | 2022 | |
| Avanos Medical | $173.96 | 2019-2025 | Standard Rf Disposables |
| Biodelivery Sciences International, INC. | $151.84 | 2020-2021 | |
| Si-Bone, INC. | $143.91 | 2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $123.66 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.20 | 2019-2021 | |
| Stimwave Technologies Incorporated | $119.14 | 2020 | |
| Medtronic, INC. | $114.60 | 2021-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Spr Therapeutics, INC | $110.94 | 2020-2023 | Sprint Pns System |
| Allergan, INC. | $102.35 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $92.18 | 2024-2025 | Recorlev |
| Medtronic USA, INC. | $76.19 | 2019-2020 | |
| Pfizer INC. | $68.10 | 2020-2023 | |
| Forte Bio-Pharma LLC | $64.09 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $61.49 | 2021-2023 | Belbuca |
| Recordati_rare_diseases_inc. | $49.76 | 2025 | Isturisa |
| Stryker Corporation | $42.98 | 2021 | |
| Averitas Pharma INC. | $39.91 | 2025 | Qutenza |
| Grt US Holding, INC. | $36.15 | 2021 | |
| Painteq LLC | $34.01 | 2024 | Painteq |
| Bioventus LLC | $26.21 | 2023 | Durolane |
| Biotronik Nro, INC. | $23.99 | 2025 | Prospera |
| Baudax Bio INC. | $22.19 | 2020 | |
| Ferring Pharmaceuticals INC. | $21.03 | 2025 | Euflexxa |
| Novo Nordisk INC | $20.52 | 2025 | Wegovy |
| Dexcom, INC. | $20.37 | 2025 | Dexcom G6 Transmitter |
| Acella Pharmaceuticals, LLC | $19.29 | 2025 | NP Thyroid 60 |
| Tonix Medicines, INC. | $19.09 | 2025 | Tonmya |
| Bayer Healthcare Pharmaceuticals INC. | $18.10 | 2025 | |
| Pacira Therapeutics, INC. | $17.13 | 2019 | |
| Valinor Pharma, LLC | $16.76 | 2024 | Movantik |
| Endo Pharmaceuticals INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kreiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.